Noticias de LQDA_US
Noticias del mercado
Últimas noticias sobre LQDA_US — 496 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Liquidia Corporation (LQDA) is up 28.1% today. Here is some analysis on what might have caused this
Liquidia (NASDAQ:LQDA) Sees Large Volume Increase Following Analyst Upgrade
Needham & Company LLC reduced their price target on shares of Liquidia from $72.00 to $58.00 and set a "buy" rating on the stock in a research report on Wednesday.
BTIG Research upgraded shares of Liquidia from a "neutral" rating to a "buy" rating and set a $70.00 price objective on the stock in a research report on Wednesday.
Oct 14 () - Liquidia shares jumped nearly 40% in premarket trading on Wednesday after the drugmaker settled a years-long legal dispute with United Therapeutics over its lung disease drug. The settlement, announced late on Tuesday, ends six lawsuits over patents, trade secrets, contracts and antitrust claims related to Liquidia
BTIG upgraded Liquidia to ‘Buy’ from ‘Neutral’ with a $70 price target, implying about 93% upside from current levels.
Another $145.4M from Liquidia covers ongoing Yutrepia sales to PH-ILD patients, payable in two $72.7M installments by January 31 and April 30, 2027.
Página 3 de 25